These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8641357)

  • 1. Interaction between a murine myeloma cell line and bone marrow stromal cells.
    Bradley TR; Kriegler AB; Verschoor SM; Tzelepis SM; Cooper IA
    Exp Hematol; 1996 Feb; 24(2):307-9. PubMed ID: 8641357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.
    Alici E; Konstantinidis KV; Aints A; Dilber MS; Abedi-Valugerdi M
    Exp Hematol; 2004 Nov; 32(11):1064-72. PubMed ID: 15539084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
    Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
    Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
    Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
    Frondoza CG; Sinha S; Trivedi SM; Humphrey RL; Colvin OM
    Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
    Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
    Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
    Barton BE; Murphy TF
    Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse.
    Vanderkerken K; De Greef C; Asosingh K; Arteta B; De Veerman M; Vande Broek I; Van Riet I; Kobayashi M; Smedsrod B; Van Camp B
    Br J Cancer; 2000 Feb; 82(4):953-9. PubMed ID: 10732771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of multiple myeloma cell growth].
    Simizu S; Konda S
    Rinsho Ketsueki; 1993 Apr; 34(4):418-22. PubMed ID: 8510327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
    Menu E; Asosingh K; Indraccolo S; De Raeve H; Van Riet I; Van Valckenborgh E; Vande Broek I; Fujii N; Tamamura H; Van Camp B; Vanderkerken K
    Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.
    Buske C; Hiddemann W; Wörmann B
    Cell Biol Int; 1994 Nov; 18(11):1049-58. PubMed ID: 7894389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purging of myeloma cells using all-trans retinoic acid in a mouse model.
    Henry JM; Morley AA; Sykes PJ
    Exp Hematol; 2001 Mar; 29(3):315-21. PubMed ID: 11274759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanisms of myeloma cell growth].
    Shimizu S
    Nihon Rinsho; 1995 Mar; 53(3):557-63. PubMed ID: 7699885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse.
    Manning LS; Berger JD; O'Donoghue HL; Sheridan GN; Claringbold PG; Turner JH
    Br J Cancer; 1992 Dec; 66(6):1088-93. PubMed ID: 1457349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone can inhibit the proliferation of myeloma cells and the interleukin-6 production of bone marrow mononuclear cells from patients with myeloma.
    Liu S; Ishikawa H; Li FJ; Ma Z; Otsuyama K; Asaoku H; Abroun S; Zheng X; Tsuyama N; Obata M; Kawano MM
    Cancer Res; 2005 Mar; 65(6):2269-76. PubMed ID: 15781640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.